Reilly Financial Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Reilly Financial Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-30	Closed	-$2K	–	913
2020 Q2	$2K	Hold	30	–	–	﹤0.01%	826
2020 Q1	$2K	Sell	30 -220	-88%	-$13.4K	﹤0.01%	801
2019 Q4	$16K	Sell	250 -10,232	-98%	-$623K	﹤0.01%	547
2019 Q3	$594K	Sell	10,482 -19,175	-65%	-$1.1M	0.07%	131
2019 Q2	$1.78M	Buy	29,657 +2,742	+10%	+$168K	0.22%	83
2019 Q1	$1.75M	Sell	26,915 -805	-3%	-$52.9K	0.23%	86
2018 Q4	$1.73M	Buy	27,720 +1,830	+7%	+$124K	0.25%	84
2018 Q3	$1.9M	Sell	25,890 -1,545	-6%	-$111K	0.25%	73
2018 Q2	$1.84M	Buy	+27,435	New	+$1.76M	0.26%	66
2017 Q1	–	Sell	-100	Closed	-$6K	–	949
2016 Q4	$6K	Buy	+100	New	+$5.76K	﹤0.01%	639
2015 Q2	–	Sell	-100	Closed	-$8K	–	1408
2015 Q1	$8K	Buy	+100	New	+$7.35K	﹤0.01%	907

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

AWMS

Advocacy Wealth Management Services Atlanta, Georgia $2.75B AUM 19.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Reilly Financial Advisors's PJP Position: Q3 2020 in Review

Reilly Financial Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2020, closing a stake of 30 shares — an estimated $2K sold.

Reilly Financial Advisors first reported a position in PJP in Q1 2015 and held it in 11 quarters. The position peaked at $1.9M in Q3 2018. 83 funds tracked by Wall St. Rank hold PJP as of Q3 2020.

Reilly Financial Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
Reilly Financial Advisors sold 30 Invesco Pharmaceuticals ETF shares in Q3 2020, an estimated $2K.
Reilly Financial Advisors first reported a position in Invesco Pharmaceuticals ETF in Q1 2015 and held it in 11 quarters.
Reilly Financial Advisors's Invesco Pharmaceuticals ETF position peaked at $1.9M in Q3 2018.
83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2020.

Based on Reilly Financial Advisors's 13F filing for Q3 2020, filed 6 Nov 2020.